Fun fact: the dorsalis pedis pulse is congenitally absent in approximately 10% of individuals. Conversely, the absence of a posterior tibial pulse is always abnormal #FOAMed #MedEd Ido Weinberg, MD nejm.org/doi/pdf/10.105…

I am thrilled to share our recent study, which reveals that hx of anxiety & depression significantly elevates risk of developing DVT, with risk level comparable to other traditional DVT risk factors. Our findings demonstrate that these psychiatric conditions appear to increase

Study reveals a divergent platelet transcriptome in patients with lipedema and lymphedema, shedding light on unique molecular mechanisms. #MedicalResearch #Lipedema #Lymphedema Alliefair Scalise🫀🧫 Scott Cameron 🏴󠁧󠁢󠁳󠁣󠁴󠁿🇺🇸🫀🩺📟🔬🧫🧬🥋

Beta-Blockers after Myocardial Infarction and Preserved Ejection Fraction. WHAT ?!? Sir James Black would not like this but always room for refinement. #Pharmacology. nejm.org/doi/full/10.10…

I still hear some say that ultrasound guidance for femoral arterial access isn't necessary & doesn't reduce complications. This CircInterventions meta-analysis suggests otherwise. You need to develop proficiency with U/S to get the best results ahajournals.org/doi/full/10.11…

Inotropes overview Cali Clark, DO MBA Eunice Dugan, MD CardioNerds #CardioEd #CriticalCare

Coexistence of Erythromelalgia and Raynaud’s Phenomenon consultqd.clevelandclinic.org/coexistence-of… via @clevelandclinic

Cellular and Enzymatic Features of Thrombi in Humans Are Vascular Bed-Dependent. ashpublications.org/bloodvth/artic… Pulkit Chaudhury Leben Tefera Anu Aggarwal Society for Vascular Medicine | SVM

Outstanding talk by Dr Darren McGuire on CV benefits of GLP1 agonist and a great resource on using them ahajournals.org/doi/epub/10.11…

myth busting: you don't need to anticoagulate patients with intra-aortic balloon pumps if you doubt this, walk from the CCU to the CTICU and see how surgeons manage IABPs (hint: surgeons are extremely mindful about avoiding hemorrhagic post-op complications)

Lipoprotein a is a risk factor for stent restenosis. #MedEd academic.oup.com/eurjpc/article…

Back to ECMO here in Georgia Heart Institute and love it. Here’s why a retro perfusion cannula (that I started in Centre universitaire de santé McGill) is better than an antegrade (see below)

The HOST-EXAM trial showed that clopidogrel monotherapy is superior to aspirin monotherapy as chronic maintenance therapy among patients who had successfully completed the required duration of #DAPT therapy post–DES #PCI. Read 🆕 updates here: bit.ly/3Hw0qdV #cvACS

The .TRI.Fr trial showed that among patients with ≥ severe symptomatic TR, T-TEER with TriClip + OMT was superior to OMT alone in improving patient symptoms, KCCQ score, and the severity of TR at 1 year. Read the latest updates here: bit.ly/3X22kJo #HeartFailure

A nice review article to start the year. sciencedirect.com/science/articl…

1/ Cardiovascular diseases, including heart disease and stroke, claim more lives in the U.S. than all forms of cancer and accidental deaths – the #2 and #3 causes of death – combined. The 2025 Statistics Update is now available.

🔴Differential Diagnosis for a Prolonged PT and aPTT 🔸If the PT and the aPTT are both prolonged, there could be multiple factors affected in the intrinsic and extrinsic pathways or a single factor deficiency in the common pathway: FX, FV, Fll or severe fibrinogen deficiency.

Delighted to share the new 2025 AHA/ACC guidelines for the management of patients with acute coronary syndrome. Especially happy about our inclusion of aggressive lipid management with non-statins and our emphasis on the importance of cardiac rehabilitation. Thanks to Sunil V. Rao

🚨New paper out: Long-Term Outcomes of Mechanical Thrombectomy vs. Catheter-Directed Thrombolysis We found a higher risk of CTEPH with thrombectomy. We need more data!! Grateful to the amazing team and the mentorship of Leben Tefera. 👇Read more: sciencedirect.com/science/articl…

Presented at #ESCCongress: In patients with heart failure and reduced ejection fraction who were receiving guideline-directed medical therapy, digitoxin lowered the risk of death or hospitalization for heart failure as compared with placebo. Full DIGIT-HF phase 4 trial results: